A grant for diabetes research in Massachusetts was issued to the Joslin Diabetes Center. In addition to this unprecedented grant, the Joalin Diabetes Center matched the grant with $5.8 million raised from Joslin donors. The total of $10.8 million will be used to build a comprehensive Translational Center for the Cure of Diabetes at Joslin’s location in the heart of Boston’s Longwood Medical Area.

The focus of the Translational Center for the Cure of Diabetes will be to step up the continued efforts for clinical and research endeavors. In addition, the facility will offer the most up-to-date infrastructure, including new labs and new platforms to accelerate the translational studies for type 1 and type 2 diabetes cures and the complications.

One of the purposes of the Massachusetts Life Sciences Center’s grant program is to contribute to the “culture of innovation” in Massachusetts. The mission of Joslin is to prevent, treat and cure diabetes. The collaboration between Joslin and Massachusettes Life Sciences Center will transcend diabetes research.

The unique advantage this new 20,000 square foot facility offers is a one-stop workplace to expedite the end goal to benefit diabetes.  This is made possible by new research approaches immediately applied by Joslin’s clinical team in an interactive and supportive environment. Waste not, want not. Time is of the essence. This new approach greatly reduces the element of time in the equation.

Visit Your Diabetes Health for more resources about health.